NCT03321344

Brief Summary

Single arm pilot study to evaluate the safety and initial feasibility of the Neurolyser XR, a new portable high intensity focused ultrasound device, for noninvasive thermal ablation of medial nerve branches of painful lumbar facet joint/s

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 25, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

December 5, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2019

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 19, 2020

Completed
Last Updated

January 25, 2021

Status Verified

July 1, 2020

Enrollment Period

1.2 years

First QC Date

October 18, 2017

Last Update Submit

January 22, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • NRS

    Reduction in average pain score as measured by a numeric rating scale from 0 (no pain) to 10, worst possible pain

    Base line, 2 days 1, 2 & 4 weeks, 3, 6 & 12 months after procedure

  • RMD

    Reduction in Rolland Morris Disability Questionnaire score

    Base line, 1 & 4 weeks, 3, 6 & 12 months after procedure

  • Saftey

    Safety will be measured by the incidence and severity of treatment related adverse events

    Base line, Procedure day, 2 days 1, 2 & 4 weeks, 3, 6 & 12 months after procedure

Study Arms (1)

Test Arm

EXPERIMENTAL

Focused Ultrasound Thermal ablation of the Medial Nerve Branch

Device: Focused Ultrasound Thermal ablation

Interventions

Focused Ultrasound Thermal ablation of the Medial Nerve Branch

Test Arm

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult male and females, legally able and willing to participate in the study and come for follow-up visits
  • Able and willing to fill the study forms and to communicate with investigator
  • Patient with uni or bilateral lumbar facetogenic pain of \> 6 months duration
  • Patients presenting with a) a positive (\>70% pain relief) to a previous L1 to L5 lumbar medial branch block and / or b) with a positive (\>70% pain relief) to a previous lumbar facet thermal RF denervation within the last 6 months)
  • Average pain score of 4 or higher in the last month, (on a scale of 0 to 10)

You may not qualify if:

  • Pregnant or breastfeeding patient
  • Patients younger than 18 or older than 80 years
  • Patients presenting with neurological deficits (including lumbosacral radiculopathy but not radicular pain).
  • History of spine surgery
  • Presence of metal hardware at the lumbosacral spine
  • Lumbar spine pathology that may increase procedural risk and / or influence symptoms and / or generate unrelated adverse event, (per the discretion of the study PI)
  • Patients unable to understand and complete the research questionnaires in English or French
  • Any severe medical condition preventing the patient from safely and effectively being treated in the study or reporting study outcome.
  • Patient with extensive scarring in the skin and tissue overlying the treatment area.
  • Patients enrolled in or planned to be enrolled in another clinical trial during the duration of this research project

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alan Edwards Pain Management Unit - Montreal General Hospital

Montreal, Quebec, H3G 1A4, Canada

Location

Related Publications (1)

  • Perez J, Gofeld M, Leblang S, Hananel A, Aginsky R, Chen J, Aubry JF, Shir Y. Fluoroscopy-Guided High-Intensity Focused Ultrasound Neurotomy of the Lumbar Zygapophyseal Joints: A Clinical Pilot Study. Pain Med. 2022 Jan 3;23(1):67-75. doi: 10.1093/pm/pnab275.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single arm, non-randomized
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2017

First Posted

October 25, 2017

Study Start

December 5, 2017

Primary Completion

February 28, 2019

Study Completion

February 19, 2020

Last Updated

January 25, 2021

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations